Cencora, Inc. (COR) is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern.Shares of this Zacks Rank #3 (Hold) company have risen 10.3% year to date compared with the industry’s 7.4% growth. The S&P 500 Index has risen 17.7% in the same time frame.Cencora is one of the world’s largest pharmaceutical service companies, focused on providing drug distribution and related services to reduce healthcare costs and improve p ...